OTC · Biotechnology

OncoVista Innovative Therapies, Inc. (OVIT) Stock

$0.00 OTC: OVIT Healthcare

OncoVista Innovative Therapies, Inc. does not have significant business.

Valuation

MetricValue
Price$0.00
Market Cap$2356
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.12
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE50.00%
ROA—
ROCE51.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20102011201220132014
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-2.0M$-2.0M$-2.0M$-3.0M
Net Profit$10.0M$-2.0M$-2.0M$-1.0M$-3.0M
EPS$-0.11$-0.10$-0.08$-0.07$-0.12
Op Margin—————

Balance Sheet (USD)

Metric20102011201220132014
Total Assets$4.0M$2.0M$1.0M$0$0
Total Liabilities$2.0M$2.0M$2.0M$3.0M$6.0M
Cash$4.0M$2.0M$1.0M$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20102011201220132014
Operating Cash Flow$-1.0M$-2.0M$-2.0M$0$0
Investing Cash Flow$6.0M$0$0$0$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$3.0M$-1.0M$-2.0M$0$0
Free Cash Flow$-1.0M$-2.0M$-2.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.08
FCF Yield-9863.50%
Quick Ratio0.00
Interest Coverage-305.91
Return 1Y0.00%
Return 3Y-50.00%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Safeguard Financial, LLC 1,3002023-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTHAnthera Pharmaceuticals, Inc. $0.00 — 0.00 $2618 0.00%
COTQFCotinga Pharmaceuticals Inc. $0.00 — 0.00 $2199 0.00%
FORUForU Holdings, Inc. $0.00 — 0.00 $2171 0.00%
LPTILongport, Inc. $0.00 — — $2308 0.00%
NEWGGreenwind Holdings Inc. $0.00 — -0.11 $2260 0.00%

About OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.

OncoVista Innovative Therapies, Inc. (OVIT) stock trades at $0.00 with a market capitalization of $2356. The stock is valued at price-to-book of 0.00, price-to-sales of 0.00.

On profitability, OncoVista Innovative Therapies, Inc. generates a return on equity (ROE) of 50.00%, above the typical market range of roughly 12-15%, return on capital employed of 51.29%.

Official website: www.oncovista.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.